Predicting Liver Disease Risk Using a Combination of Common Clinical Markers: A Screening Model from Routine Health Check-Up

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2020 Jun 23

PMID 32566041

Citations 1

Authors

Yi Wang

Yanni Li

Xiaoyi Wang

Ranko Gacesa

Jie Zhang

Lu Zhou

Bangmao Wang

Affiliations

Soon will be listed here.

Abstract

Background: Early detection is crucial for the prognosis of patients with autoimmune liver disease (AILD). Due to the relatively low incidence, developing screening tools for AILD remain a challenge.

Aims: To analyze clinical characteristics of AILD patients at initial presentation and identify clinical markers, which could be useful for disease screening and early detection.

Methods: We performed observational retrospective study and analyzed 581 AILD patients who were hospitalized in the gastroenterology department and 1000 healthy controls who were collected from health management center. Baseline characteristics at initial presentation were used to build regression models. The model was validated on an independent cohort of 56 patients with AILD and 100 patients with other liver disorders.

Results: Asymptomatic AILD individuals identified by the health check-up are increased yearly (from 31.6% to 68.0%, < 0.001). The cirrhotic rates at an initial presentation are decreased in the past 18 years (from 52.6% to 20.0%, < 0.001). Eight indicators, which are common in the health check-up, are independent risk factors of AILD. Among them, abdominal lymph node enlargement (LN) positive is the most significant different (OR 8.85, 95% CI 2.73-28.69, < 0.001). The combination of these indicators shows high predictive power (AUC = 0.98, sensitivity 89.0% and specificity 96.4%) for disease screening. Except two liver or cholangetic injury makers, the combination of AGE, GENDER, GLB, LN, concomitant extrahepatic autoimmune diseases, and familial history also shows a high predictive power for AILD in other liver disorders ( = 0.91).

Conclusion: Screening for AILD with described parameters can detect AILD in routine health check-up early, effectively and economically. Eight variables in routine health check-up are associated with AILD and the combination of them shows good ability of identifying high-risk individuals.

Citing Articles

Effects of drinking slightly acidic electrolyzed water on the growth health, blood physiology, and intestinal development in mice.

Shi Z, Xi L, Gao S, Shi Z, Wang X, Ye Z Sci Rep. 2025; 15(1):7578.

PMID: 40038362 PMC: 11880203. DOI: 10.1038/s41598-025-91614-8.

Noninvasive diagnosis of AIH/PBC overlap syndrome based on prediction models.

Wang K, Li Y, Pan J, He H, Zhao Z, Guo Y Open Med (Wars). 2022; 17(1):1550-1558.

PMID: 36245703 PMC: 9520330. DOI: 10.1515/med-2022-0526.

References

van der Poorten D, Kenny D, Butler T, George J . Liver disease in adolescents: A cohort study of high-risk individuals. Hepatology. 2007; 46(6):1750-8. DOI: 10.1002/hep.21918. View

Carey E, Ali A, Lindor K . Primary biliary cirrhosis. Lancet. 2015; 386(10003):1565-75. DOI: 10.1016/S0140-6736(15)00154-3. View

Trivedi P, Hirschfield G . Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther. 2012; 36(6):517-33. DOI: 10.1111/j.1365-2036.2012.05223.x. View

Guo L, Zhou L, Zhang N, Deng B, Wang B . Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists. Gastroenterol Res Pract. 2017; 2017:2376231. PMC: 5278196. DOI: 10.1155/2017/2376231. View

Lee Y, Teo E, Ng T, Khor C, Fock K . Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J Gastroenterol Hepatol. 2002; 16(12):1384-9. DOI: 10.1046/j.1440-1746.2001.02646.x. View

Efe C, Wahlin S, Ozaslan E, Berlot A, Purnak T, Muratori L . Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol. 2012; 24(5):531-4. DOI: 10.1097/MEG.0b013e328350f95b. View

Boberg K, Chapman R, Hirschfield G, Lohse A, Manns M, Schrumpf E . Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol. 2010; 54(2):374-85. DOI: 10.1016/j.jhep.2010.09.002. View

Floreani A, Liberal R, Vergani D, Mieli-Vergani G . Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun. 2013; 46:7-16. DOI: 10.1016/j.jaut.2013.08.004. View

Nevens F, Andreone P, Mazzella G, Strasser S, Bowlus C, Invernizzi P . A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med. 2016; 375(7):631-43. DOI: 10.1056/NEJMoa1509840. View

10.

Feld J, Dinh H, Arenovich T, Marcus V, Wanless I, Heathcote E . Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005; 42(1):53-62. DOI: 10.1002/hep.20732. View

11.

Liberal R, Grant C . Cirrhosis and autoimmune liver disease: Current understanding. World J Hepatol. 2016; 8(28):1157-1168. PMC: 5055585. DOI: 10.4254/wjh.v8.i28.1157. View

12.

To U, Silveira M . Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis. Clin Liver Dis. 2018; 22(3):603-611. DOI: 10.1016/j.cld.2018.03.010. View

13.

Udell J, Wang C, Tinmouth J, FitzGerald J, Ayas N, Simel D . Does this patient with liver disease have cirrhosis?. JAMA. 2012; 307(8):832-842. DOI: 10.1001/jama.2012.186. View

14.

Soresi M, Bonfissuto G, Magliarisi C, Riili A, Terranova A, Di Giovanni G . Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis. Clin Radiol. 2003; 58(5):372-7. DOI: 10.1016/s0009-9260(03)00055-2. View

15.

Barreiros A, Chiorean L, Braden B, Dietrich C . Ultrasound in rare diffuse liver disease. Z Gastroenterol. 2014; 52(11):1247-56. DOI: 10.1055/s-0034-1384996. View

16.

Younossi Z, Loomba R, Anstee Q, Rinella M, Bugianesi E, Marchesini G . Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 2017; 68(1):349-360. PMC: 6511364. DOI: 10.1002/hep.29721. View

17.

Carbone M, Neuberger J . Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2013; 60(1):210-23. DOI: 10.1016/j.jhep.2013.09.020. View

18.

Jepsen P, Gronbaek L, Vilstrup H . Worldwide Incidence of Autoimmune Liver Disease. Dig Dis. 2015; 33 Suppl 2:2-12. DOI: 10.1159/000440705. View

19.

Rovlias A, Kotsou S . Classification and regression tree for prediction of outcome after severe head injury using simple clinical and laboratory variables. J Neurotrauma. 2004; 21(7):886-93. DOI: 10.1089/0897715041526249. View

20.

. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015; 63(4):971-1004. DOI: 10.1016/j.jhep.2015.06.030. View